1. World Health Organization. Asthma [Internet]. Geneva: WHO; 2023. [Accessed on: September 09, 2025]. Available from URL: https://www.who.int/news-room/fact-sheets/detail/asthma

2. GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020;8(6):585-96. https://doi.org/10.1016/S2213-2600(20)30105-3

3. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2023 Update [Internet]. [Accessed on: September 09, 2025]. Available from URL: https://ginasthma.org

4. Johnson M. Molecular mechanisms of β₂-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 2006;117(1):18-24 https://doi.org/10.1016/j.jaci.2005.11.012

5. Liggett SB. Polymorphisms of the β₂-adrenergic receptor and asthma. Am J Respir Crit Care Med 1999;159(3 Suppl):S165-70. https://doi.org/10.1164/ajrccm.156.4.12tac-15

6. Rebordosa C, Kogevinas M, Guerra S, Castro-Giner F, Jarvis D, Cazzoletti L, et al. ADRB2 Gly16Arg polymorphism, asthma control and lung function decline. Eur Respir J 2011;38(5):1029-35. https://doi.org/10.1183/09031936.00146310

7. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, et al. Complex promoter and coding region β₂-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000;97(19):10483-8. https://doi.org/10.1073/pnas.97.19.10483

8. Green SA, Turki J, Hall IP, Liggett SB. Implications of genetic variability of human β₂-adrenergic receptor structure. Pulm Pharmacol Ther 1995;8(1):1-10. https://doi.org/10.1006/pulp.1995.1001

9. Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, et al. The effect of polymorphisms of the β₂-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162(1):75-80. https://doi.org/10.1164/ajrccm.162.1.9907092

10. Wechsler ME, Lehman E, Lazarus SC, Lemanske RF Jr, Boushey HA, Deykin A, et al. β-adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006;173(5):519-26. https://doi.org/10.1164/rccm.200509-1519oc

11. Hall IP, Blakey JD. Polymorphisms of the β₂-adrenoceptor gene and asthma. Clin Exp Allergy 2005;35(4):386-9.

12. Zhao S, Zhang W, Nie X. Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis. BMC Pulm Med 2019;19(1):202. https://doi.org/10.1186/s12890-019-0962-z

13. Karimi L, Vijverberg SJ, Engelkes M, Hernandez-Pacheco N, Farzan N, Soares P, et al. ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis. Clin Exp Allergy 2021;51(9):1157-71. https://doi.org/10.1111/cea.13965

14. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2023 Update [Internet]. [Accessed on: September 09, 2025]. Available from URL: https://ginasthma.org

15. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007;119(4):817-25. https://doi.org/10.1016/j.jaci.2006.12.662

16. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL et al. Standardization of spirometry 2019 update. Eur Respir J 2019;53(2):1801055. https://doi.org/10.1183/13993003.01055-2018

17. Kurmi OP, Lam KB, Ayres JG. Indoor air pollution and the lung in low- and medium-income countries. Eur Respir J 2012;40(1):239-54. https://doi.org/10.1183/09031936.00190211

18. Salam MT, Islam T, Gilliland FD. Recent evidence for adverse effects of residential proximity to traffic sources on asthma. Curr Opin Pulm Med 2008;14(1):3-8. https://doi.org/10.1097/MCP.0b013e3282f1987a

19. PiCA Consortium. ADRB2 haplotypes and asthma exacerbations in children and young adults. J Clin Pharmacol 2021;61(4):531-40. https://doi.org/10.1002/jcph.1779

20. Muchão FP, Souza AV, Souza JM, Santos CB, Ferrari GF, Leone C et al. Association between beta-2 adrenergic receptor variants and clinical outcomes in children and adolescents with acute asthma. Einstein (Sao Paulo) 2022;20:eAO6412. https://doi.org/10.31744/einstein_journal/2022AO6412

21. Jiang Y, Wang Y, Zhang X, Wu Y, Xu H, Lu C et al. Association between ADRB2 polymorphisms and asthma susceptibility: an updated systematic review and meta-analysis. BMC Pulm Med 2020;20:234. https://doi.org/10.1186/s12890-020-01265-6

22. Ortega VE, Meyers DA, Bleecker ER. Asthma pharmacogenetics and the development of genetic profiles for personalized medicine. Pharmacol Ther 2021;217:107661. https://doi.org/10.1016/j.pharmthera.2020.107661

23. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 2021;27(1):1-7. https://doi.org/10.1097/MCP.0000000000000738

24. Pino-Yanes M, Williams LK. Emerging pharmacogenetic insights into beta-2 adrenergic receptor function in asthma. Curr Opin Pulm Med 2020;26(1):82-9. https://doi.org/10.1097/MCP.0000000000000649

25. Wechsler ME, Szefler SJ. Personalized asthma management: moving toward precision medicine. Lancet Respir Med 2021;9(11):1179-90. https://doi.org/10.1016/S2213-2600(21)00246-3

26. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 2009;15(1):39-45. https://doi.org/10.1097/mcp.0b013e32831da894

27. Perez-Garcia J, Espuela-Ortiz A, Lorenzo-Diaz F, Pino-Yanes M. Pharmacogenetics of Pediatric Asthma: Current Perspectives. Pharmgenomics Pers Med 2020;13:89-103. https://doi.org/10.2147/PGPM.S201276